Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-Center, Long-Term Follow-up Study to Evaluate the Safety of PHX1149T in Subjects With Type 2 Diabetes Mellitus - Extension to Protocol PHX1149-PROT202

NCT01101945 is registered in ClinicalTrials.gov with Phenomix as lead sponsor.

NCT NCT01101945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01101945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-Center, Long-Term Follow-up Study to Evaluate the Safety of PHX1149T in Subjects With Type 2 Diabetes Mellitus - Extension to Protocol PHX1149-PROT202
Lead sponsor
Phenomix
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2007
Completion date
March 31, 2010
Enrollment
339 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus